{"entity":{"type":"insider","cik":"0001985547","url":"/insider/0001985547","json_url":"/insider/0001985547.json","name":"Ma Songjiang","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":86,"n_filings":39,"first":"2024-12-19","last":"2025-05-29","span_basis":"filed_date"},"name_variants":[{"name":"Ma Songjiang","source":"filing","n_filings":39,"first_seen":"2024-12-19","last_seen":"2025-05-29"}],"transactions":[{"id":4297386,"accession":"0001140361-25-020754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-020754","line_url":"/filing/0001140361-25-020754#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":558.0,"shares_display":"558","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":5619.06,"total_display":"5,619.06","total_whole":"5,619","shares_owned_after":2806084.0,"shares_owned_after_display":"2,806,084","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-29","scope":"insider"},{"id":4297383,"accession":"0001140361-25-020754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-020754","line_url":"/filing/0001140361-25-020754#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.28,"price_display":"10.28","price_state":"stated","total_value":20560.0,"total_display":"20,560.00","total_whole":"20,560","shares_owned_after":2806642.0,"shares_owned_after_display":"2,806,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":4371436,"accession":"0001140361-25-020474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-020474","line_url":"/filing/0001140361-25-020474#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182.0,"shares_display":"182","price_per_share":10.24,"price_display":"10.24","price_state":"stated","total_value":1863.68,"total_display":"1,863.68","total_whole":"1,864","shares_owned_after":2808642.0,"shares_owned_after_display":"2,808,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4371432,"accession":"0001140361-25-020474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-020474","line_url":"/filing/0001140361-25-020474#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":21940.0,"total_display":"21,940.00","total_whole":"21,940","shares_owned_after":2808824.0,"shares_owned_after_display":"2,808,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-27","scope":"insider"},{"id":4065643,"accession":"0001140361-25-020156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-020156","line_url":"/filing/0001140361-25-020156#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.83,"price_display":"10.83","price_state":"stated","total_value":21660.0,"total_display":"21,660.00","total_whole":"21,660","shares_owned_after":2810824.0,"shares_owned_after_display":"2,810,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-21","filed_date":"2025-05-22","scope":"insider"},{"id":4065642,"accession":"0001140361-25-020156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-020156","line_url":"/filing/0001140361-25-020156#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":2812824.0,"shares_owned_after_display":"2,812,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":5107121,"accession":"0001140361-25-019893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-019893","line_url":"/filing/0001140361-25-019893#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":22220.0,"total_display":"22,220.00","total_whole":"22,220","shares_owned_after":2814824.0,"shares_owned_after_display":"2,814,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-20","scope":"insider"},{"id":5107116,"accession":"0001140361-25-019893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-019893","line_url":"/filing/0001140361-25-019893#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":22620.0,"total_display":"22,620.00","total_whole":"22,620","shares_owned_after":2816824.0,"shares_owned_after_display":"2,816,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":4795060,"accession":"0001140361-25-019468","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-019468","line_url":"/filing/0001140361-25-019468#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.68,"price_display":"10.68","price_state":"stated","total_value":21360.0,"total_display":"21,360.00","total_whole":"21,360","shares_owned_after":2818824.0,"shares_owned_after_display":"2,818,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-16","scope":"insider"},{"id":4795055,"accession":"0001140361-25-019468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-019468","line_url":"/filing/0001140361-25-019468#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":226.0,"total_display":"226.00","total_whole":"226","shares_owned_after":2820824.0,"shares_owned_after_display":"2,820,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-16","scope":"insider"},{"id":4530405,"accession":"0001140361-25-018927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-018927","line_url":"/filing/0001140361-25-018927#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.37,"price_display":"11.37","price_state":"stated","total_value":22740.0,"total_display":"22,740.00","total_whole":"22,740","shares_owned_after":2820844.0,"shares_owned_after_display":"2,820,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-14","scope":"insider"},{"id":4530400,"accession":"0001140361-25-018927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-018927","line_url":"/filing/0001140361-25-018927#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.56,"price_display":"10.56","price_state":"stated","total_value":21120.0,"total_display":"21,120.00","total_whole":"21,120","shares_owned_after":2822844.0,"shares_owned_after_display":"2,822,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":4350697,"accession":"0001140361-25-010234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-010234","line_url":"/filing/0001140361-25-010234#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174.0,"shares_display":"174","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1740.0,"total_display":"1,740.00","total_whole":"1,740","shares_owned_after":2824844.0,"shares_owned_after_display":"2,824,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-25","scope":"insider"},{"id":5024361,"accession":"0001140361-25-009877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-009877","line_url":"/filing/0001140361-25-009877#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.09,"price_display":"10.09","price_state":"stated","total_value":20180.0,"total_display":"20,180.00","total_whole":"20,180","shares_owned_after":2825018.0,"shares_owned_after_display":"2,825,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":5024355,"accession":"0001140361-25-009877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-009877","line_url":"/filing/0001140361-25-009877#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.13,"price_display":"10.13","price_state":"stated","total_value":20260.0,"total_display":"20,260.00","total_whole":"20,260","shares_owned_after":2827018.0,"shares_owned_after_display":"2,827,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4530350,"accession":"0001140361-25-009424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-009424","line_url":"/filing/0001140361-25-009424#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":10.24,"price_display":"10.24","price_state":"stated","total_value":2478.08,"total_display":"2,478.08","total_whole":"2,478","shares_owned_after":2829018.0,"shares_owned_after_display":"2,829,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-19","scope":"insider"},{"id":4530344,"accession":"0001140361-25-009424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-009424","line_url":"/filing/0001140361-25-009424#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":24180.0,"total_display":"24,180.00","total_whole":"24,180","shares_owned_after":2829260.0,"shares_owned_after_display":"2,829,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":5107051,"accession":"0001140361-25-009017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-009017","line_url":"/filing/0001140361-25-009017#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.31,"price_display":"12.31","price_state":"stated","total_value":24620.0,"total_display":"24,620.00","total_whole":"24,620","shares_owned_after":2831260.0,"shares_owned_after_display":"2,831,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-17","scope":"insider"},{"id":5107042,"accession":"0001140361-25-009017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-009017","line_url":"/filing/0001140361-25-009017#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":23600.0,"total_display":"23,600.00","total_whole":"23,600","shares_owned_after":2833260.0,"shares_owned_after_display":"2,833,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-17","scope":"insider"},{"id":4269919,"accession":"0001140361-25-008623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-008623","line_url":"/filing/0001140361-25-008623#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.74,"price_display":"11.74","price_state":"stated","total_value":23480.0,"total_display":"23,480.00","total_whole":"23,480","shares_owned_after":2835260.0,"shares_owned_after_display":"2,835,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-13","scope":"insider"},{"id":4269914,"accession":"0001140361-25-008623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-008623","line_url":"/filing/0001140361-25-008623#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.4,"price_display":"11.40","price_state":"stated","total_value":22800.0,"total_display":"22,800.00","total_whole":"22,800","shares_owned_after":2837260.0,"shares_owned_after_display":"2,837,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":4844200,"accession":"0001140361-25-008091","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-008091","line_url":"/filing/0001140361-25-008091#line-4","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":20280.0,"total_display":"20,280.00","total_whole":"20,280","shares_owned_after":2839260.0,"shares_owned_after_display":"2,839,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-11","scope":"insider"},{"id":4844194,"accession":"0001140361-25-008091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-008091","line_url":"/filing/0001140361-25-008091","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.248055,"price_display":"10.25","price_state":"stated","total_value":20496.11,"total_display":"20,496.11","total_whole":"20,496","shares_owned_after":2841260.0,"shares_owned_after_display":"2,841,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider","n_lines":3},{"id":4170473,"accession":"0001140361-25-007602","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-007602","line_url":"/filing/0001140361-25-007602#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.8,"price_display":"10.80","price_state":"stated","total_value":21600.0,"total_display":"21,600.00","total_whole":"21,600","shares_owned_after":2843260.0,"shares_owned_after_display":"2,843,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":4170469,"accession":"0001140361-25-007602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-007602","line_url":"/filing/0001140361-25-007602#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.98,"price_display":"10.98","price_state":"stated","total_value":21960.0,"total_display":"21,960.00","total_whole":"21,960","shares_owned_after":2845260.0,"shares_owned_after_display":"2,845,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":4044100,"accession":"0001140361-25-007173","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-007173","line_url":"/filing/0001140361-25-007173#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.86,"price_display":"10.86","price_state":"stated","total_value":21720.0,"total_display":"21,720.00","total_whole":"21,720","shares_owned_after":2847260.0,"shares_owned_after_display":"2,847,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":4044098,"accession":"0001140361-25-007173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-007173","line_url":"/filing/0001140361-25-007173#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.23,"price_display":"11.23","price_state":"stated","total_value":22460.0,"total_display":"22,460.00","total_whole":"22,460","shares_owned_after":2849260.0,"shares_owned_after_display":"2,849,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4878599,"accession":"0001140361-25-006738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-006738","line_url":"/filing/0001140361-25-006738#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":22820.0,"total_display":"22,820.00","total_whole":"22,820","shares_owned_after":2851260.0,"shares_owned_after_display":"2,851,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":4878592,"accession":"0001140361-25-006738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-006738","line_url":"/filing/0001140361-25-006738#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.33,"price_display":"11.33","price_state":"stated","total_value":22660.0,"total_display":"22,660.00","total_whole":"22,660","shares_owned_after":2853260.0,"shares_owned_after_display":"2,853,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider"},{"id":4297230,"accession":"0001140361-25-006273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-006273","line_url":"/filing/0001140361-25-006273#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":23260.0,"total_display":"23,260.00","total_whole":"23,260","shares_owned_after":2855260.0,"shares_owned_after_display":"2,855,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-27","scope":"insider"},{"id":4297224,"accession":"0001140361-25-006273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-006273","line_url":"/filing/0001140361-25-006273#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.37,"price_display":"11.37","price_state":"stated","total_value":22740.0,"total_display":"22,740.00","total_whole":"22,740","shares_owned_after":2857260.0,"shares_owned_after_display":"2,857,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider"},{"id":4577288,"accession":"0001140361-25-005842","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-005842","line_url":"/filing/0001140361-25-005842","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.68602,"price_display":"10.69","price_state":"stated","total_value":21372.04,"total_display":"21,372.04","total_whole":"21,372","shares_owned_after":2859447.0,"shares_owned_after_display":"2,859,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider","n_lines":2},{"id":4577279,"accession":"0001140361-25-005842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-005842","line_url":"/filing/0001140361-25-005842","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.90916,"price_display":"11.91","price_state":"stated","total_value":23818.32,"total_display":"23,818.32","total_whole":"23,818","shares_owned_after":2861442.0,"shares_owned_after_display":"2,861,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-25","scope":"insider","n_lines":2},{"id":4700214,"accession":"0001140361-25-005420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-005420","line_url":"/filing/0001140361-25-005420#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":24800.0,"total_display":"24,800.00","total_whole":"24,800","shares_owned_after":2863260.0,"shares_owned_after_display":"2,863,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":4700206,"accession":"0001140361-25-005420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-005420","line_url":"/filing/0001140361-25-005420#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":24580.0,"total_display":"24,580.00","total_whole":"24,580","shares_owned_after":2865260.0,"shares_owned_after_display":"2,865,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4201167,"accession":"0001140361-25-005113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-005113","line_url":"/filing/0001140361-25-005113#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.49,"price_display":"12.49","price_state":"stated","total_value":24980.0,"total_display":"24,980.00","total_whole":"24,980","shares_owned_after":2867260.0,"shares_owned_after_display":"2,867,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":4201164,"accession":"0001140361-25-005113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-005113","line_url":"/filing/0001140361-25-005113#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.94,"price_display":"11.94","price_state":"stated","total_value":23880.0,"total_display":"23,880.00","total_whole":"23,880","shares_owned_after":2869260.0,"shares_owned_after_display":"2,869,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"},{"id":4878533,"accession":"0001140361-25-004744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-004744","line_url":"/filing/0001140361-25-004744#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":23380.0,"total_display":"23,380.00","total_whole":"23,380","shares_owned_after":2871260.0,"shares_owned_after_display":"2,871,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":4878528,"accession":"0001140361-25-004744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-004744","line_url":"/filing/0001140361-25-004744#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.49,"price_display":"11.49","price_state":"stated","total_value":22980.0,"total_display":"22,980.00","total_whole":"22,980","shares_owned_after":2873260.0,"shares_owned_after_display":"2,873,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider"},{"id":4577266,"accession":"0001140361-25-004126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-004126","line_url":"/filing/0001140361-25-004126#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1878.0,"shares_display":"1,878","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":21634.56,"total_display":"21,634.56","total_whole":"21,635","shares_owned_after":2875260.0,"shares_owned_after_display":"2,875,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":4577260,"accession":"0001140361-25-004126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-004126","line_url":"/filing/0001140361-25-004126#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.9,"price_display":"11.90","price_state":"stated","total_value":23800.0,"total_display":"23,800.00","total_whole":"23,800","shares_owned_after":2877138.0,"shares_owned_after_display":"2,877,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":4269871,"accession":"0001140361-25-003831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-003831","line_url":"/filing/0001140361-25-003831#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.16,"price_display":"12.16","price_state":"stated","total_value":24320.0,"total_display":"24,320.00","total_whole":"24,320","shares_owned_after":2879158.0,"shares_owned_after_display":"2,879,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-07","filed_date":"2025-02-11","scope":"insider"},{"id":4269867,"accession":"0001140361-25-003831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-003831","line_url":"/filing/0001140361-25-003831#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.85,"price_display":"12.85","price_state":"stated","total_value":25700.0,"total_display":"25,700.00","total_whole":"25,700","shares_owned_after":2881138.0,"shares_owned_after_display":"2,881,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-06","filed_date":"2025-02-11","scope":"insider"},{"id":4844117,"accession":"0001140361-25-003426","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-003426","line_url":"/filing/0001140361-25-003426","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.3945,"price_display":"12.39","price_state":"stated","total_value":24789.0,"total_display":"24,789.00","total_whole":"24,789","shares_owned_after":2883158.0,"shares_owned_after_display":"2,883,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-06","scope":"insider","n_lines":2},{"id":4844108,"accession":"0001140361-25-003426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-003426","line_url":"/filing/0001140361-25-003426#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"GYRE THERAPEUTICS, INC.","issuer_ticker":"GYRE","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001985547","owner_name":"Ma Songjiang","owner_display_name":"Ma Songjiang","owner_url":"/insider/0001985547","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.62,"price_display":"11.62","price_state":"stated","total_value":23240.0,"total_display":"23,240.00","total_whole":"23,240","shares_owned_after":2885138.0,"shares_owned_after_display":"2,885,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"}],"collapsed":true,"next_cursor":"2025-02-04|4844108","ledger_fault":false,"count":{"value":86,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":86,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":86},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001124105","name":"GYRE THERAPEUTICS, INC.","url":"/issuer/0001124105","role":"Director, Officer (President)","n_filings":39,"first_seen":"2024-12-19","last_seen":"2025-05-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001985547","retrieved_at":"2026-08-23T00:36:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}